Technical Analysis for EVFM - Evofem Biosciences, Inc.

Grade Last Price % Change Price Change
grade B 5.41 3.84% 0.20
EVFM closed up 3.84 percent on Friday, May 24, 2019, on 77 percent of normal volume.
2 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical EVFM trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Crossed Above 20 DMA Bullish 3.84%
Calm After Storm Range Contraction 3.84%
Wide Bands Range Expansion 3.84%
Fell Below 20 DMA Bearish 11.32%
1,2,3 Pullback Bullish Bullish Swing Setup 11.32%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 11.32%
Calm After Storm Range Contraction 11.32%
Wide Bands Range Expansion 11.32%
Down 3 Days in a Row Weakness 11.32%

Older signals for EVFM ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:

Profile
Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.
Pharmaceutical Obesity
Is EVFM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 23 Ekso Bionics and Tonix Pharmaceuticals among healthcare gainers; T2 Biosystems and Biocept among losers
May 15 Midday Gainers / Losers
May 15 Catalyst Pharmaceuticals and Genetic Technologies among healthcare gainers; ImmunoGen leads the losers
May 14 Evofem Biosciences to Present at 2019 RBC Capital Markets Global Healthcare Conference
May 13 72 Biggest Movers From Friday
May 12 Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q1 2019 Results - Earnings Call Transcript
May 10 BPL, GH, PBYI and JMIA among notable midday movers
May 10 Evofem Biosciences and G1 Therapeutics among healthcare gainers; TransEnterix leads the losers
May 10 PDL BioPharma (PDLI) Q1 Earnings Top Mark, Revenues Rise Y/Y
May 9 PDL Biopharma Inc (PDLI) Q1 2019 Earnings Call Transcript
See more EVFM news...
Indicators
Indicator Value
52 Week High 7.24
52 Week Low 1.79
Average Volume 82,212
200-Day Moving Average 3.7248
50-Day Moving Average 4.2562
20-Day Moving Average 5.053
10-Day Moving Average 5.472
Average True Range 0.5721
ADX 34.86
+DI 24.8408
-DI 14.3863
Chandelier Exit (Long, 3 ATRs ) 5.5237
Chandelier Exit (Short, 3 ATRs ) 5.4413
Upper Bollinger Band 6.8409
Lower Bollinger Band 3.2651
Percent B (%b) 0.6
BandWidth 70.765882
MACD Line 0.3289
MACD Signal Line 0.4011
MACD Histogram -0.0723
Fundamentals Value
Market Cap 74.81 Million
Num Shares 13.8 Million
EPS -0.74
Price-to-Earnings (P/E) Ratio -7.31
Price-to-Sales 0.00
Price-to-Book 2.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.10
Resistance 3 (R3) 6.11 5.90 5.99
Resistance 2 (R2) 5.90 5.72 5.89 5.95
Resistance 1 (R1) 5.65 5.61 5.78 5.64 5.91
Pivot Point 5.44 5.44 5.50 5.43 5.44
Support 1 (S1) 5.19 5.26 5.32 5.18 4.91
Support 2 (S2) 4.98 5.15 4.97 4.87
Support 3 (S3) 4.73 4.98 4.84
Support 4 (S4) 4.72